{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus Junin : Questions médicales les plus fréquentes",
"headline": "Virus Junin : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus Junin : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-21",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus Junin"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Arénavirus du Nouveau Monde",
"url": "https://questionsmedicales.fr/mesh/D006477",
"about": {
"@type": "MedicalCondition",
"name": "Arénavirus du Nouveau Monde",
"code": {
"@type": "MedicalCode",
"code": "D006477",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.480.500.070.095"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus Junin",
"alternateName": "Junin virus",
"code": {
"@type": "MedicalCode",
"code": "D018051",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Cheng Huang",
"url": "https://questionsmedicales.fr/author/Cheng%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America."
}
},
{
"@type": "Person",
"name": "Slobodan Paessler",
"url": "https://questionsmedicales.fr/author/Slobodan%20Paessler",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America."
}
},
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand. duncan_r_smith@hotmail.com."
}
},
{
"@type": "Person",
"name": "Vahid Rajabali Zadeh",
"url": "https://questionsmedicales.fr/author/Vahid%20Rajabali%20Zadeh",
"affiliation": {
"@type": "Organization",
"name": "Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan."
}
},
{
"@type": "Person",
"name": "Shuzo Urata",
"url": "https://questionsmedicales.fr/author/Shuzo%20Urata",
"affiliation": {
"@type": "Organization",
"name": "Department of Emerging Infectious Diseases, National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Nagasaki, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36251860",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13506129.2022.2131384"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39346594",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1385089"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reward network dysfunction is associated with cognitive impairment after stroke.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37307650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nicl.2023.103446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of cognitive dysfunction one-year post COVID-19.",
"datePublished": "2023-01-05",
"url": "https://questionsmedicales.fr/article/36603126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/neu0000876"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive Dysfunction Biomarkers in Patients With Rheumatoid Arthritis: A Systematic Review.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36729842",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RHU.0000000000001888"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN de polarité négative",
"item": "https://questionsmedicales.fr/mesh/D000086103"
},
{
"@type": "ListItem",
"position": 5,
"name": "Arenaviridae",
"item": "https://questionsmedicales.fr/mesh/D001116"
},
{
"@type": "ListItem",
"position": 6,
"name": "Arenavirus",
"item": "https://questionsmedicales.fr/mesh/D018050"
},
{
"@type": "ListItem",
"position": 7,
"name": "Arénavirus du Nouveau Monde",
"item": "https://questionsmedicales.fr/mesh/D006477"
},
{
"@type": "ListItem",
"position": 8,
"name": "Virus Junin",
"item": "https://questionsmedicales.fr/mesh/D018051"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus Junin - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus Junin",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus Junin",
"description": "Comment diagnostique-t-on l'infection par le virus Junin ?\nQuels tests sont utilisés pour confirmer le virus Junin ?\nLes symptômes aident-ils au diagnostic du virus Junin ?\nPeut-on diagnostiquer le virus Junin par culture virale ?\nLe diagnostic précoce est-il important pour le virus Junin ?",
"url": "https://questionsmedicales.fr/mesh/D018051?mesh_terms=Cognitive+Dysfunction&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus Junin",
"description": "Quels sont les symptômes de l'infection par le virus Junin ?\nLa fièvre est-elle un symptôme courant du virus Junin ?\nLes symptômes du virus Junin peuvent-ils varier ?\nY a-t-il des symptômes neurologiques associés au virus Junin ?\nLes symptômes apparaissent-ils rapidement après l'infection ?",
"url": "https://questionsmedicales.fr/mesh/D018051?mesh_terms=Cognitive+Dysfunction&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus Junin",
"description": "Comment prévenir l'infection par le virus Junin ?\nLa vaccination contre le virus Junin est-elle disponible ?\nQuelles mesures d'hygiène sont recommandées ?\nLes rongeurs sont-ils un vecteur de transmission ?\nLes voyageurs doivent-ils se vacciner contre le virus Junin ?",
"url": "https://questionsmedicales.fr/mesh/D018051?mesh_terms=Cognitive+Dysfunction&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus Junin",
"description": "Quel est le traitement principal pour l'infection par le virus Junin ?\nDes antiviraux sont-ils efficaces contre le virus Junin ?\nLa transfusion sanguine est-elle utilisée dans le traitement ?\nLe traitement précoce améliore-t-il le pronostic ?\nY a-t-il des traitements expérimentaux pour le virus Junin ?",
"url": "https://questionsmedicales.fr/mesh/D018051?mesh_terms=Cognitive+Dysfunction&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus Junin",
"description": "Quelles sont les complications possibles de l'infection par le virus Junin ?\nLes complications surviennent-elles souvent ?\nLe virus Junin peut-il causer des séquelles à long terme ?\nLes complications sont-elles plus fréquentes chez certains groupes ?\nComment gérer les complications du virus Junin ?",
"url": "https://questionsmedicales.fr/mesh/D018051?mesh_terms=Cognitive+Dysfunction&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus Junin",
"description": "Quels sont les principaux facteurs de risque pour le virus Junin ?\nLes agriculteurs sont-ils à risque d'infection par le virus Junin ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nLe sexe influence-t-il le risque d'infection par le virus Junin ?\nLes personnes vivant en milieu urbain sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D018051?mesh_terms=Cognitive+Dysfunction&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'infection par le virus Junin ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et PCR pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le virus Junin ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et la PCR sont couramment utilisés pour confirmer l'infection."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic du virus Junin ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent le diagnostic, mais des tests sont nécessaires."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer le virus Junin par culture virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture virale est possible mais moins courante en raison des risques de contagion."
}
},
{
"@type": "Question",
"name": "Le diagnostic précoce est-il important pour le virus Junin ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un diagnostic précoce permet une prise en charge rapide et améliore le pronostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'infection par le virus Junin ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, myalgies, fatigue, et parfois des hémorragies."
}
},
{
"@type": "Question",
"name": "La fièvre est-elle un symptôme courant du virus Junin ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre est l'un des symptômes les plus fréquents de l'infection."
}
},
{
"@type": "Question",
"name": "Les symptômes du virus Junin peuvent-ils varier ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier d'une personne à l'autre."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés au virus Junin ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques peuvent survenir, notamment des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement après l'infection ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes apparaissent généralement 1 à 3 semaines après l'exposition au virus."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus Junin ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'évitement des contacts avec les rongeurs et la vaccination."
}
},
{
"@type": "Question",
"name": "La vaccination contre le virus Junin est-elle disponible ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une vaccination est disponible et recommandée pour les populations à risque."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures d'hygiène strictes, comme le nettoyage des lieux infestés, sont essentielles."
}
},
{
"@type": "Question",
"name": "Les rongeurs sont-ils un vecteur de transmission ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les rongeurs sont les principaux réservoirs et vecteurs du virus Junin."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils se vacciner contre le virus Junin ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs se rendant dans des zones endémiques doivent envisager la vaccination."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'infection par le virus Junin ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est principalement symptomatique, avec des soins de soutien en cas de gravité."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils efficaces contre le virus Junin ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antiviraux spécifiques approuvés pour le virus Junin."
}
},
{
"@type": "Question",
"name": "La transfusion sanguine est-elle utilisée dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des transfusions peuvent être nécessaires en cas de complications hémorragiques sévères."
}
},
{
"@type": "Question",
"name": "Le traitement précoce améliore-t-il le pronostic ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement précoce et approprié peut améliorer le pronostic des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour le virus Junin ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des traitements expérimentaux, mais rien n'est encore validé."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'infection par le virus Junin ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des hémorragies, des troubles neurologiques et la mort."
}
},
{
"@type": "Question",
"name": "Les complications surviennent-elles souvent ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares mais peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Le virus Junin peut-il causer des séquelles à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles neurologiques peuvent persister après la guérison de l'infection."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains groupes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées sont plus à risque de complications sévères."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications du virus Junin ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite des soins médicaux intensifs et un suivi approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le virus Junin ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition aux rongeurs et le travail en zones endémiques."
}
},
{
"@type": "Question",
"name": "Les agriculteurs sont-ils à risque d'infection par le virus Junin ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les agriculteurs travaillant dans des zones infestées par des rongeurs sont à risque."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles présentent un risque accru de développer des formes graves de la maladie."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque d'infection par le virus Junin ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que le risque peut varier selon le sexe, mais les raisons ne sont pas claires."
}
},
{
"@type": "Question",
"name": "Les personnes vivant en milieu urbain sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque est généralement plus faible en milieu urbain, mais des cas sporadiques peuvent survenir."
}
}
]
}
]
}
Cognitive dysfunction is part of the broad spectrum of clinical manifestations in older untreated hereditary transthyretin amyloidosis patients with peripheral polyneuropathy....
The objective of this study is to systematically explore cognitive dysfunction in ATTRV30M amyloidosis patients whose disease course was modified by liver transplant (LT)....
A series of 269 carriers of TTRVal30Met mutation treated with LT underwent a neuropsychological assessment. Clinical charts were reviewed to identify focal neurological episodes (FNEs), cognitive comp...
Cognitive dysfunction was identified in 35 patients (13%)-14 (5%) had mild and 21 (8%) had moderate dysfunction. In comparison to normal cognition, both mild and moderate cognitive dysfunction patient...
Consistent with the natural history of the disease, older age and higher severity of the disease are significantly associated and potentially predictors of cognitive dysfunction in ATTRV30M patients t...
The impact of cardiovascular diseases on cognition raises important research questions. The study aimed to investigate the relationship between demographic data, cardiovascular diseases, kidney diseas...
A cross-sectional study of patients with cardiovascular diseases was performed. The Montreal Cognitive Assessment (MoCA) was applied for cognitive evaluation. Based on MoCA three groups were defined: ...
Of 628 patients, 55.2% had mild CD, and the mean age was 67.95 (SD 9.53) years. Cα and Mω were 0.7, indicating good internal consistency. We found a moderate positive correlation between depression an...
Mild CD was the most common in patients with cardiovascular diseases. Older age, lower education, being a non-smoker, and renal dysfunction were risk factors for both mild and advanced CD. Female gend...
Stroke survivors not only suffer from severe motor, speech and neurocognitive deficits, but in many cases also from a "lack of pleasure" and a reduced motivational level. Especially apathy and anhedon...
(a) To characterize the frequency of objective cognitive deficits and self-perceived cognitive difficulties and (b) to explore demographic and clinical predictors of cognitive dysfunction and cognitiv...
One hundred and ten adults diagnosed with COVID-19 between March and November 2020, aged ≤ 74 years underwent a brief neuropsychological evaluation 12 months after infection, which included: Brief Vis...
Twenty participants (18.2%) had cognitive dysfunction and 36 (33.3%) had cognitive complaints. Cognitive dysfunction was related to lower education, preinfection history of headache/migraine, and acut...
A subset of individuals develops cognitive difficulties in the context of post-COVID syndrome. Results may support the protective effect of education, a known proxy of cognitive reserve. COVID-19 infe...
During the last years, a growing number of studies have investigated the link between cognitive dysfunction and rheumatoid arthritis (RA), highlighting the potential pathogenic role of several clinica...
We performed a systematic review using PRISMA (Preferred Reported Items for Systematic Reviews and Meta-analysis) protocol. A systematic search was conducted in the PubMed/MEDLINE, EMBASE, LILACS, Sco...
Five original studies were included, which provided data from 428 participants. Among plasma proteins, SHH was increased and TTR was reduced in patients with mild cognitive impairment; anti-myelin bas...
Despite the relative scarcity of studies on this subject and the heterogeneity of results, we identified possible biomarkers for cognitive deficits in the RA population. Further longitudinal studies a...
Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) with a well-documented role in the innate and adaptive immune responses. Interestingly, TLR activation has also been linked to sever...
The origin of pre-existing cognitive impairment in stroke patients remains controversial, with a vascular or a degenerative hypothesis....
To determine whether endothelial dysfunction is associated with pre-existing cognitive problems, lesion load and biological anomalies in stroke patients....
Patients originated from the prospective STROKDEM study. The baseline cognitive state, assessed using the IQ-CODE, and risk factors for stroke were recorded at inclusion. Patients with an IQ-CODE scor...
A total of 86 patients were included (52 males; mean age 63.5 ± 11.5 years). Patients with abnormal RHI have hypertension or antihypertensive treatment more often. The baseline IQ-CODE was abnormal in...
A vascular mechanism may be responsible for cognitive problems pre-existing stroke. The measurement of endothelial dysfunction after stroke could become an important element of follow-up, providing an...
There is increasing recognition of the prevalence and impact of cognitive dysfunction (CD) in heart failure (HF) patients. This contemporary review appraises the evidence for epidemiological associati...
CD disproportionately affects heart failure patients, even accounting for known comorbid risk factors, and this may extend to subclinical left ventricular dysfunction. Neuroimaging studies now provide...
Cognitive dysfunction is increasingly recognized as a complication and comorbidity of diabetes, supported by evidence of abnormal brain structure and function. Although few mechanistic metabolic studi...
There is limited data on cognition in patients undergoing peritoneal dialysis (PD). We assessed prevalence and associated risk factors of neurocognitive impairment (NCI) in PD patients....
A cross-sectional cohort study of 149 PD patients at a single centre between 2016 and 2020 who underwent neurocognitive screening at defined intervals by Addenbrooke's Cognitive Examination - Revised ...
Patients on PD performed poorly in ACE-R screening compared to population norms, with discrepancy in all cognitive domains. In patients without CVD, attention and language domains were comparable to n...
Patients on PD have higher prevalence of NCI than the general population, primarily with impairments in memory, fluency and visuospatial reasoning. CVD confers poorer performance in attention and lang...